Page last updated: 2024-08-24

3-iodobenzylguanidine and Hypoventilation

3-iodobenzylguanidine has been researched along with Hypoventilation in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Eriguchi, M; Fujioka, S; Hara, H; Hattori, N; Houzen, H; Li, Y; Mishima, T; Nishioka, K; Sato, K; Shiomi, K; Tsuboi, Y; Yabe, I1
Borght, TV; Krug, B; Lacrosse, M; Luyx, D; Pirson, AS; Tuerlinckx, D1

Other Studies

2 other study(ies) available for 3-iodobenzylguanidine and Hypoventilation

ArticleYear
Meta-iodobenzylguanidine myocardial scintigraphy in Perry disease.
    Parkinsonism & related disorders, 2021, Volume: 83

    Topics: 3-Iodobenzylguanidine; Aged; Autonomic Nervous System Diseases; Biomarkers; Depression; Dynactin Complex; Female; Humans; Hypoventilation; Japan; Magnetic Resonance Imaging; Male; Middle Aged; Myocardial Perfusion Imaging; Parkinsonian Disorders; Pedigree; Radiopharmaceuticals

2021
Additional value of I-123 MIBG SPECT in neuroblastoma.
    Clinical nuclear medicine, 2005, Volume: 30, Issue:2

    Topics: 3-Iodobenzylguanidine; Abdominal Pain; Child, Preschool; Fever of Unknown Origin; Humans; Hypoventilation; Lung Neoplasms; Male; Neuroblastoma; Radiography; Radiopharmaceuticals; Tomography, Emission-Computed, Single-Photon

2005